Form 4 for HIMS Hims & Hers Health, Inc.
Accepted 2024-01-03 00:00:00 ET · period of report 2023-12-29 · accession 0001773751-24-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-01-03 | 2023-12-29 | HIMS | Baird Melissa | COO | M - OptEx | $2.01 | +93.0K | 471.8K | +25% | +$187.0K |
| DM | 2024-01-03 | 2023-12-29 | HIMS | Baird Melissa | COO | M - OptEx | $0.00 | -93.0K | 743.4K | -11% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-12-29 | M | A | 35,661 | $2.43 | 507,465 | D | — | — | |
| 2 | Common | Class A Common Stock | 2023-12-29 | M | A | 57,339 | $1.75 | 471,804 | D | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2023-12-29 | M | D | 57,339 | $0.00 | 55,906 | D | $1.75 · — to 2029-11-06 | 57,339 Class A Common Stock | (F1) Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 250,000 shares of Hims, Inc., with an exercise price of $0.79. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 113,245 shares of the Company with an exercise price of $1.75. 100% of the shares subject to the option have vested. |
| 4 | Derivative | Stock Option (right to buy) | 2023-12-29 | M | D | 35,661 | $0.00 | 743,412 | D | $2.43 · — to 2030-05-13 | 35,661 Class A Common Stock | (F2) Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 1,719,884 shares of Hims, Inc., with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 779,073 shares of the Company with an exercise price of $1.75. The shares subject to the option will be fully vested on February 12, 2024, subject to the Reporting Person's continuous service. The option is also subject to acceleration in the event the Reporting Person is subject to a qualifying involuntary termination of employment and/or Change of Control (as such term is defined in the applicable Stock Option Agreement). |